-

Urology of St. Louis is First Facility in Region to Adopt Innovative New Laser Treatment for Enlarged Prostate

ST. LOUIS--(BUSINESS WIRE)--Urology of St. Louis (USL), the largest private urologic practice in St. Louis and the Metro East, has become the only facility in the region to conduct surgery for benign enlarged prostate using the MOSES™ 2.0 Pulse 120H by Lumenis, an advancement in minimally invasive laser technology.

In 2019, William Critchlow, M.D., of USL, became one of the first physicians in St. Louis and the surrounding region to offer holmium laser enucleation of the prostate (HoLEP), a specialized surgery for the treatment of benign prostatic hyperplasia (BPH). During the procedure, which is recommended for these patients by the American Urologic Association, Dr. Critchlow uses a laser to remove tissue that is blocking urine flow through the prostate.

Having learned to conduct HoLEP during his training at Mayo Clinic, Dr. Critchlow performs the procedure several times per week at USL and is thrilled that his patients will now experience the added benefits associated with the cutting-edge MOSES 2.0 technology.

“MOSES 2.0 offers an innovative precision technology that has been shown to improve the versatility, speed, accuracy, and efficiency of surgery for BPH,” Dr. Critchlow said. “By minimizing the length of surgery, I expect the technology to reduce the amount of time my patients spend under anesthesia, thus promoting faster recovery and a quicker return to their homes. In addition, the efficiencies associated with the MOSES 2.0 laser will carry over to the scheduling side of our practice, making it easier for us to quickly accommodate those who need treatment for BPH.”

Appropriate for anyone with BPH, regardless of prostate size or history of taking anticoagulation drugs,1,2 MOSES 2.0 has been shown to reduce operating time by 20%, or about 25 minutes, compared with traditional holmium laser enucleation of the prostate, and with 30% less blood loss.3 In addition, HoLEP conducted with the MOSES 2.0 laser is typically a same-day procedure that allows patients to return home catheter-free.1,4

USL offers treatment for a wide range of urological conditions including prostate cancer, pelvic organ prolapse, incontinence, sexual health, benign prostatic hyperplasia, kidney stones, kidney cancer, vasectomies and erectile dysfunction. For more information about their telehealth services or to find a list of locations, visit their website at stlurology.com/ or email at info@stlurology.com.

Cutline: Urology of St. Louis is First Facility in Region to Adopt Innovative New Laser Treatment for Enlarged Prostate.

References:

1. Krambeck AE, et al. 2020. Doi.org/10.1016/j.urology.2019.11.029.

2. Krambeck AE, et al. 2020. Doi: 10.1089/end.2020.0886.

3. Kavoussi NL, et al. 2021. Doi: 10.1097/JU.0000000000001693.

4. Krambeck AE, et al. 2020. Doi: 10.1016/j.urology.2020.09.038.

Contacts

Jessica Williams
618-772-2349
jwilliams@bammarketingagency.com

Urology of St. Louis


Release Versions

Contacts

Jessica Williams
618-772-2349
jwilliams@bammarketingagency.com

Social Media Profiles
More News From Urology of St. Louis

Lumenis OptiLight Wins 2022 MedTech Breakthrough Award: Best New Technology Solution for Ophthalmology

YOKNE’AM ILLIT, Israel--(BUSINESS WIRE)--Lumenis Be., a leading energy-based medical device company for aesthetic and eye care applications, today announced that OptiLight has received the highly competitive MedTech Breakthrough Award for “Best New Technology Solution for Ophthalmology.” This year, MedTech’s range of health and medical technology categories attracted more than 3,900 nominations from over 15 countries, from which MedTech selected OptiLight for this prestigious recognition. The w...

Mandy Moore Partners With Lumenis to Raise Awareness of Dry Eye Disease and OptiLight Treatment

YOKNE’AM ILLIT, Israel--(BUSINESS WIRE)--Lumenis today announced that it has partnered with singer-songwriter and actress Mandy Moore as a brand ambassador for OptiLight, a bright solution for dry eyes. Ms. Moore suffered from dry eye disease and treatment with OptiLight significantly improved her condition. Now she’s partnering with Lumenis to share her story and empower others. She will star in OptiLight’s new campaign, showing millions of dry eye sufferers that they don’t have to “just live...

Copper Ridge Surgery Center Becomes First ASC in Region to Introduce MOSES Laser

TRAVERSE CITY, Mich.--(BUSINESS WIRE)--Copper Ridge Surgery Center, Michigan’s state-of-the-art freestanding ambulatory surgery center (ASC), has become the first ASC facility in the northern part of the state to offer same-day treatment of kidney stones and benign enlarged prostate using the MOSES™ Pulse 120H by Lumenis, an advancement in minimally invasive laser technology. The center’s adoption of the gold-standard equipment was essential to its recent creation of a urology center designed t...
Back to Newsroom